Table 4 The differences in DCE in patients with bpMRI ≥3 (n, %)
From: Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer
|  | Non-PCa (n = 48) | PCa (n = 109) | P* | Non-csPCa (n = 66) | csPCa (n = 91) | P* |
|---|---|---|---|---|---|---|
bpMRI ≥3 (n = 157) |  |  | 0.001 |  |  | 0.001 |
DCE (−) | 19 (39.6) | 17 (15.6) |  | 24 (36.4) | 12 (13.2) |  |
DCE (+) | 29 (60.4) | 92 (84.4) | Â | 42 (63.6) | 79 (86.8) | Â |
bpMRI = 3 (n = 29) |  |  | 0.286 |  |  | 0.943 |
DCE (−) | 9 (52.9) | 4 (33.3) |  | 10 (47.6) | 3 (37.5) |  |
DCE (+) | 8 (47.1) | 8 (66.7) | Â | 11 (52.4) | 5 (62.5) | Â |
bpMRI = 4 (n = 58) |  |  | 0.003 |  |  | < 0.001 |
DCE (−) | 9 (56.3) | 6 (14.3) |  | 12 (52.2) | 3 (8.6) |  |
DCE (+) | 7 (43.8) | 36 (85.7) | Â | 11 (47.8) | 32 (91.4) | Â |
bpMRI = 5 (n = 70) |  |  | 0.844 |  |  | 0.991 |
DCE (−) | 1 (6.7) | 7 (12.7) |  | 2 (9.1) | 6 (12.5) |  |
DCE (+) | 14 (93.3) | 48 (87.3) | Â | 20 (90.9) | 42 (87.5) | Â |